Apremilast (Otezla ▼): risk of suicidal thoughts and behaviour

There is an increased risk that some patients may experience psychiatric symptoms with apremilast, including depression and suicidal thoughts. Stop treatment if patients have new psychiatric symptoms or if existing symptoms worsen.